Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A newly designed anticancer tumor immunity drug delivery system.

A Sugitachi1, T Shindo, Y Matsuda

  • 1Department of Surgery, Osaka National Hospital, Japan.

ASAIO Transactions
|July 1, 1991
PubMed
Summary

A novel fibrin clot drug delivery system achieved sustained release of anti-cancer drugs, significantly improving survival rates and inducing anti-tumor immune responses in rats.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantification of Lung Perfusion Blood Volume by Dual-Energy CT in Patients With and Without Chronic Obstructive Pulmonary Disease.

Journal of the Belgian Society of Radiology·2018
Same author

A two-year follow-up of surgical and non-surgical treatments in patients with masticatory muscle tendon-aponeurosis hyperplasia.

International journal of oral and maxillofacial surgery·2017
Same author

Efficacy and safety of systemic chemotherapy and intra-arterial chemotherapy with/without radiotherapy for bladder preservation or as neo-adjuvant therapy in patients with muscle-invasive bladder cancer: a single-centre study of 163 patients.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2014
Same author

Distinguishing adrenal adenomas from non-adenomas on dynamic enhanced CT: a comparison of 5 and 10 min delays after intravenous contrast medium injection.

Clinical radiology·2013
Same author

Fate of aorta and clinical outcomes in patients with chronic type B aortic dissection: over 20-year experience.

The Journal of cardiovascular surgery·2012
Same author

Nizatidine improves clinical symptoms and gastric emptying in patients with functional dyspepsia accompanied by impaired gastric emptying.

Digestion·2012

Area of Science:

  • Biomedical Engineering
  • Oncology
  • Drug Delivery Systems

Background:

  • Sustained drug release is crucial for effective cancer therapy.
  • Traditional chemotherapy often results in rapid drug clearance and systemic toxicity.
  • Developing novel drug carriers can improve therapeutic outcomes and reduce side effects.

Purpose of the Study:

  • To evaluate a fibrin clot (FC) as a carrier for sustained release of anti-cancer drugs (ADs).
  • To assess the in vivo efficacy and immunologic effects of FC-encapsulated ADs compared to conventional administration.
  • To investigate the potential of FC-AD systems for cancer treatment.

Main Methods:

  • Adriamycin (ADM) and cis-platinum (CDDP) were encapsulated into fibrin clots (FC-AD).
  • In vitro drug release profiles of FC-AD were analyzed.
  • FC-AD was administered intra-abdominally in ascites hepatoma AH130-bearing rats; control groups received intraperitoneal (IP) ADM/CDDP or no treatment.
  • Survival time and oncolytic mechanisms were investigated.

Main Results:

  • Sustained release of AD from FC continued for over 15 days.
  • Sixty-eight percent of rats treated with FC-AD survived beyond 200 days with no evidence of malignancy.
  • Control groups (IP or untreated) had high mortality within 20 days, with massive ascites and metastases.
  • Immunologic studies showed induced anti-tumor immune responses in FC-AD treated rats.

Conclusions:

  • The fibrin clot drug delivery system enables sustained release of anti-cancer drugs.
  • FC-AD treatment significantly enhances long-term survival and induces anti-tumor immunity in a rat cancer model.
  • This FC-AD system shows promising antineoplastic activity in vivo and warrants further investigation.

Related Experiment Videos